Genotoxic carcinogens called heterocyclic amines are produced during the cooking of fish and meat.
Trp-P-2 induces tumors of the liver, mammary gland, urinary bladder, clitoral gland and haematopoietic system in F344 rats at a dose of 0.01% in the diet. 3) Chlorophyllin, a water-soluble derivative of chlorophyll (CAS No. 1406-65-1), is a potent antimutagenic agent against heterocyclic amines [4] [5] [6] [7] and other environmental mutagens (for reviews, see, refs. 1, 8) . Chlorophyllin inhibits tumorigenesis in rat induced by heterocyclic amines, 2-amino-3-methylimidazo [4,5- f ]quinoline 9) and 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyrimidine. 10) The inhibition of mutagenesis induced by polycyclic planar compounds by chlorophyllin involves the binding of chlorophyllin to the mutagens. 11) We have recently found that chitosan, a poly-N-glucosamine, is suitable as a polymer-support for the molecules of chlorophyllin, and we prepared a water-insoluble complex, chlorophyllin-chitosan (chl-chitosan). 12) Leakage of chlorophyllin from chl-chitosan does not occur either in acidic or in weakly alkaline buffers (pH 1-8). 12) Our data have shown that chlorophyllin fixed on chitosan can efficiently and tightly trap Trp-P-2. Recently, we reported that the chl-chitosan can inhibit the mutagenicity and DNA adduct formation of Trp-P-2 in rpsL transgenic mice.
13)
The carcinogenicity of Trp-P-2 towards rpsL transgenic mice is not known. In female F344 rat, Trp-P-2 induces tumors of the mammary gland, clitoral gland and haematopoietic system, whereas it induces liver cancer in female ACI rat.
1) The amounts of DNA adduct of carcinogens formed in animals were different between species and strains. 14) We report here that the formation of Trp-P-2-adduct in the liver DNA of CDF 1 mice, in which Trp-P-2 had been proven to induce hepatocellular tumors and carcinomas, was suppressed by chlchitosan co-administered with Trp-P-2.
MATERIALS AND METHODS
General Cu-chlorophyllin is a product of Nacalai Tesque (Kyoto). Male CDF 1 mice at 7 weeks of age (body weight 23.5Ϯ2.5 g) were obtained from Charles River Japan (Atsugi, Japan), and the diet for the mice (CE-2) was from Clea Japan (Tokyo). [g-32 P]ATP (800 Ci/mmol, 12.5 mM) was obtained from ICN Biochemicals (Irvine, CA, U.S.A.). Chitosan, 3-amino-1-methyl-5H-pyrido [4,3-b] indole (Trp-P-2) and other agents were products of Wako Chemicals (Tokyo).
Chl-chitosan was prepared by the method previously described.
12) The chlorophyllin content of a chl-chitosan powder, as measured by the atomic absorption for copper, was 65.5%. The chl-chitosan powder was soaked in 5% Na 2 SO 4 for 10 min, the mixture was centrifuged, and the precipitate was used as chl-chitosan for further experiments.
Animal Treatments Experiment 1: Six-week-old male CDF 1 mice were given water and basal diet ad libitum for one week. Then, animals were randomly assigned to one of three groups. Group-1: Five mice were administered Trp-P-2 alone in the diet. The diet was prepared as follows. 20 ml of a Trp-P-2 (0.2 mg/ml) solution was mixed with 20 g of powdered basal diet (CE-2). The final concentration of Trp-P-2 in this diet was thus 0.02%. Group-2: Five mice were given the 'Trp-P-2ϭchl-chitosan' diet, which was prepared as follows. A solution (50 ml) of Trp-P-2 (50 mg) in 10 mM sodium phosphate buffer (pH 7.0) was added to the chl-chitosan (5 g, dry weight), which had been imbibed just before use. The mixture was shaken vigorously at room temperature for 30 min. Almost all the Trp-P-2 in the solution was adsorbed to the chl-chitosan. The mixture was centrifuged (3000 rpm, 10 min) and the precipitate, 'Trp-P-2ϭchl-chitosan', was used for feeding (13.6 g, wet weight). 1.1 grams of 'Trp-P2ϭchl-chitosan' was mixed with 20 g powdered basal diet; the final concentration of Trp-P-2 in the diet was 0.02% and that of chl-chitosan was 0.5%. Group-3: Three mice were given wet powdered basal diet as a non-treated control group.
The food was given for 3 d. The total dose of Trp-P-2 for group-1 and group-2 was 24 mg per 5 mice per 3 d. After 24 h from the last administration, mice were sacrificed by cervical dislocation and the livers were taken for analysis. Experiment 2: Mice were randomly assigned to one of six groups, each composed of three mice. Diets given were as follows: Group 1, 0.01% Trp-P-2 diet; group 2, 0.01% Trp-P-2ϩ1% chl-chitosan diet; group 3, 0.01% Trp-P-2ϩ2% chl-chitosan diet; group 4, 0.01% Trp-P-2ϩ3% chl-chitosan diet; group 5, CE-2 diet; group 6, 3% chl-chitosan diet. The preparation of the diet was as follows. An appropriate amount of chl-chitosan (or water for group 1 and group 5) was mixed with powdered CE-2 diet. Then, a Trp-P-2 solution (or water for group 5 and group 6) was added to the chl-chitosan-CE-2 diet. These diets were prepared every day immediately before feeding. Each group was given the diet for 3 d. After 24 h from the last feeding, animals were killed. Lungs were taken to examine the adduct formation by 32 Ppostlabeling.
Detection of DNA Adducts DNA was isolated from the organs using a rapid solvent-extraction procedure. 15) Adducts in DNA were analyzed by the 32 P-postlabeling method using the intensification protocol described previously. 16, 17) RESULTS AND DISCUSSION The 32 P-postlabeling of mouse DNA after treatment with Trp-P-2 or 'Trp-P-2ϭchl-chitosan' gave a single spot on TLC at a position corresponding to that reported by Yamashita et al. 18) as a C8-deoxyguanylate adduct of Trp-P-2. The intensity of the spot from mice fed Trp-P-2ϭchl-chitosan was lower compared with that from mice fed Trp-P-2 (Table 1) . Adducts observed in the liver DNA in mice fed Trp-P-2 pre-adsorbed to chl-chitosan was about two-thirds of that found in mice fed Trp-P-2 only. The difference was statistically significant (pϽ0.05). These results indicated that the pre-adsorption of Trp-P-2 to chl-chitosan can protect against the adduct formation of Trp-P-2 in CDF 1 mice. Table 2 shows the dose-dependent effects of chl-chitosan on the DNA adduct formation in lung in CDF 1 mice fed Trp-P-2 with or without chl-chitosan. DNA adducts were detected in the lung of mice given a diet containing 0.01% Trp-P-2. The formation of Trp-P-2 adducts in the lung was inhibited significantly by the co-administration of 3% chl-chitosan (pϽ0.05). The addition of 1% or 2% chi-chitosan into a diet containing Trp-P-2 tended to suppress the adduct formation. In our previous work, 13) DNA adducts were also detected in rpsL transgenic mice fed Trp-P-2 (0.01%). When chl-chitosan was added to the Trp-P-2 diet, the adduct levels were significantly reduced in the liver. Unlike in CDF 1 mice, however, the adduct level in the lung was not reduced in transgenic mice. The difference in strains may account for the disparity of results in the lung.
The adsorption of Trp-P-2 to chl-chitosan in the diet may have lowered the uptake of Trp-P-2 into the mouse body, which resulted in a reduced incidence of DNA adducts in mice. Usage of the chlorophyllin fixed on chitosan might also have an advantage for preventing side effects of chlorophyllin by minimizing absorption into the body. It is also conceivable that chl-chitosan may be a candidate as a mutagen-remover from the environment. The content of Trp-P-2 and chl-chitosan was 0.02 and 0.5%, respectively. No DNA adduct was detected in mice given the basal diet as a non-treated control group (group 3). a) Significantly different from group 1 at pϽ0.05 (Student's t-test). 
